Katuyuki Hotta

23PUBLICATIONS
85CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersPacific Peoples language educationOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jun 04, 2026
A multicenter, randomized, parallel-group confirmatory study protocol to evaluate the efficacy of Soft Protector CPC, a novel oral mucosal protectant, in preventing oral mucositis and alleviating pain in patients with breast cancer.

|Jun 02, 2026
Afatinib Overcomes Osimertinib Resistance via Egfr V804F Mutation in a Syngeneic Egfr-Mutant Lung Cancer Mouse Model.

|Feb 27, 2026
TGF-β Inhibitor Potentiates Osimertinib-Induced Anti-Tumor Immunity in Egfr-Mutant Lung Cancer.

Tadahiro Kuribayashi, Jun Nishimura, Sachi Okawa

|Jan 13, 2026
Clinical Characteristics and Spatial Transcriptome Analysis of Non-Small Cell Lung Cancers Exhibiting Early Alectinib Resistance: A Retrospective OLCSG Study.

Tadahiro Kuribayashi, Go Makimoto, Kadoaki Ohashi

|Jun 04, 2025
Guidance on the short hydration method for cisplatin administration.

Kiichiro Ninomiya, Kei Kunimasa, Yasuko Kurata

|May 29, 2025
Colony-Stimulating Factor-1 Receptor Inhibitor Augments Osimertinib-Induced Antitumor Immunity via Suppression of Macrophages in Lung Cancer Harboring EGFR Mutation.

Sachi Okawa, Shuta Tomida, Tadahiro Kuribayashi

Pageof 4

Frequent Collaborators

6 joint publications

Eiki Ichihara

6 joint publications

Kadoaki Ohashi

4 joint publications

Kiichiro Ninomiya

4 joint publications

Shuta Tomida